Filing Details
- Accession Number:
- 0001179110-11-006096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-06 15:50:02
- Reporting Period:
- 2011-04-04
- Filing Date:
- 2011-04-06
- Accepted Time:
- 2011-04-06 15:50:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1286370 | R Michael Minogue | C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923 | President, Ceo, Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Acquisiton | 2011-04-04 | 139,088 | $9.05 | 360,077 | No | 4 | M | Direct | |
Common Stock, $.01 Par Value | Disposition | 2011-04-04 | 172,986 | $15.01 | 187,091 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2011-04-04 | 94,892 | $0.00 | 94,892 | $9.05 |
Common Stock | Stock Option (right to buy) | Disposition | 2011-04-04 | 44,196 | $0.00 | 44,196 | $9.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,108 | 2005-04-05 | 2014-04-05 | No | 4 | M | Direct |
55,804 | 2005-04-05 | 2014-04-05 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $9.05 | 2005-04-05 | 2014-04-05 | 192,200 | 186,383 | Direct |
Common Stock | Stock Option (right to buy) | $9.36 | 2006-06-08 | 2015-06-08 | 100,000 | 100,000 | Direct |
Common Stock | Stock Option (right to buy) | $13.57 | 2007-06-01 | 2016-06-01 | 260,000 | 260,000 | Direct |
Common Stock | Stock Option (right to buy) | $11.27 | 2008-05-30 | 2017-05-30 | 85,000 | 85,000 | Direct |
Common Stock | Stock Option (right to buy) | $13.80 | 2009-05-23 | 2018-05-23 | 43,333 | 43,333 | Direct |
Common Stock | Stock Option (right to buy) | $18.63 | 2009-06-15 | 2018-08-13 | 93,750 | 93,750 | Direct |
Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 148,000 | 148,000 | Direct |
Common Stock | Stock Option (right to buy) | $5.86 | 2010-03-31 | 2019-05-28 | 130,500 | 130,500 | Direct |
Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 105,000 | 105,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2014-04-05 | 192,200 | 186,383 | Direct |
2015-06-08 | 100,000 | 100,000 | Direct |
2016-06-01 | 260,000 | 260,000 | Direct |
2017-05-30 | 85,000 | 85,000 | Direct |
2018-05-23 | 43,333 | 43,333 | Direct |
2018-08-13 | 93,750 | 93,750 | Direct |
2019-05-28 | 148,000 | 148,000 | Direct |
2019-05-28 | 130,500 | 130,500 | Direct |
2020-06-03 | 105,000 | 105,000 | Direct |
Footnotes
- Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 1998 Equity Incentive Plan.
- Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- Grant to reporting person of inducement option to buy shares of Common Stock under NASDAQ Marketplace Rule 4350. These options were granted outside of the Company's established stock option plans.
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable based on the achievement of certain performance milestones.
- These options become exerciseable upon the achievement of a certain performance milestone, based on the results of Abiomed's fiscal year ended March 31, 2010.
- The sale of common stock reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on 11/25/2009.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $15.00 and $15.13. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.